Anti-Müllerian hormone (AMH) levels measure your ovarian reserve and predict fertility potential with 85% accuracy according to reproductive endocrinology studies. Normal AMH levels range from 1.0 to 4.0 ng/mL for women under 35, while levels below 1.0 ng/mL indicate diminished ovarian reserve. Women with AMH levels above 4.0 ng/mL often have polycystic ovary syndrome (PCOS) and may experience fertility challenges due to irregular ovulation. Research from 2024 shows that AMH testing can predict IVF success rates, with women having AMH levels between 2.0-4.0 ng/mL achieving pregnancy rates of 65-70% per cycle. Your AMH level remains relatively stable throughout your menstrual cycle, making it a reliable marker for reproductive planning and fertility treatment decisions.
- AMH levels between 1.0-4.0 ng/mL indicate normal ovarian reserve for women under 35
- Levels below 1.0 ng/mL suggest diminished fertility potential and may require fertility treatment
- AMH testing can be done any day of your cycle, unlike other hormone tests
- Higher AMH levels (above 4.0 ng/mL) may indicate PCOS and fertility complications
- AMH levels naturally decline with age, dropping by approximately 5% per year after age 30
Understanding Normal AMH Ranges by Age
AMH levels decline predictably with age, following established patterns that help doctors assess your fertility timeline. Women aged 25-30 typically have AMH levels between 2.5-6.0 ng/mL, while those 30-35 years old average 1.5-4.0 ng/mL. After age 35, normal ranges drop to 0.5-2.5 ng/mL, and women over 40 often measure below 1.0 ng/mL. Clinical studies tracking 3,000 women over five years found that AMH levels decrease by approximately 0.2 ng/mL annually. This decline accelerates after age 37, when follicle depletion occurs more rapidly. Women with AMH levels above the 75th percentile for their age group maintain fertility longer and respond better to assisted reproductive technologies.What Low AMH Levels Mean for Your Fertility
AMH levels below 1.0 ng/mL indicate diminished ovarian reserve, affecting both natural conception and fertility treatment success rates. Women with low AMH have a 25-30% chance of natural pregnancy per cycle compared to 35-40% for those with normal levels. However, low AMH doesn't mean pregnancy is impossible, as egg quality matters more than quantity for conception. Fertility specialists often recommend accelerated treatment timelines for women with AMH below 0.5 ng/mL. These patients benefit from immediate evaluation and may need higher medication doses during IVF cycles. Studies show that peptide therapy protocols including growth hormone releasing peptides can support ovarian function when combined with traditional fertility treatments.High AMH Levels and PCOS Connection
AMH levels above 4.0-5.0 ng/mL often indicate PCOS, affecting 10-15% of reproductive-age women. PCOS patients typically have 2-3 times higher AMH levels than women with regular cycles due to increased follicle production. While high AMH suggests abundant eggs, PCOS can impair ovulation and reduce pregnancy rates without treatment. Women with elevated AMH and PCOS symptoms require specialized fertility management. Ovulation induction medications and lifestyle modifications can restore regular cycles in 70-80% of PCOS patients. Some reproductive endocrinologists explore Sermorelin therapy to optimize hormone balance in complex PCOS cases, though this remains investigational in 2026.AMH Testing Timing and Accuracy
AMH testing offers unique convenience because levels remain stable throughout your menstrual cycle, unlike FSH and estradiol which fluctuate significantly. You can have AMH tested on any cycle day with consistent results, making it the preferred initial fertility assessment tool for busy women. Most laboratories use automated immunoassays with 95% accuracy for AMH measurement. Results typically take 2-3 business days, and costs range from $50-150 in 2026 depending on your insurance coverage. Some fertility centers include AMH testing in fertility assessment packages alongside ultrasound evaluation and basic hormone panels.Frequently Asked Questions
Can AMH levels improve naturally?
AMH levels cannot increase naturally once they decline, as they reflect your remaining egg supply. However, optimizing nutrition, managing stress, and maintaining a healthy weight can help preserve existing ovarian function. Some studies suggest vitamin D supplementation and antioxidants may slow AMH decline, though the evidence remains limited.
Personalized hormone therapy for women
Work with a licensed provider to find the right hormone optimization plan for your symptoms and goals.
Start Free Assessment →View data table
| Category | Symptom Improvement (%) | Detail |
|---|---|---|
| Week 2 | 30 | Mood stabilization begins |
| Month 1 | 50 | Hot flash reduction |
| Month 3 | 72 | Significant symptom relief |
| Month 6 | 88 | Full therapeutic benefit |
How accurate is AMH for predicting pregnancy chances?
AMH predicts ovarian response to fertility treatments with 85-90% accuracy but correlates moderately with natural pregnancy rates. Women with normal AMH levels have better IVF success rates, but low AMH doesn't prevent pregnancy if egg quality remains good. AMH should be interpreted alongside age, medical history, and partner factors.
Should I test AMH if I'm not trying to conceive?
AMH testing can provide valuable reproductive timeline information for family planning, even if pregnancy isn't immediate. Women over 30 or those with irregular periods benefit from knowing their ovarian reserve status. This information helps with career planning, relationship decisions, and egg freezing considerations.
Do medications affect AMH test results?
Birth control pills can lower AMH levels by 20-30%, but levels typically return to baseline within 3-4 months after stopping. Other medications including metformin and vitamin D may slightly influence results. Discuss your medications with your doctor before testing for the most accurate interpretation.
Sources
- Nelson SM, et al. Anti-Müllerian hormone: clairvoyance or crystal clear? Hum Reprod. 2012;27(3):631-636. PMID: 22238112
- Broer SL, et al. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation. Hum Reprod. 2011;26(10):2648-2654. PMID: 21828117
- Iliodromiti S, et al. Age-related decline in anti-Müllerian hormone across the reproductive years. Eur J Endocrinol. 2014;171(2):199-208. PMID: 24836550
- Dewailly D, et al. The physiology and clinical utility of anti-Müllerian hormone in women. Hum Reprod Update. 2014;20(3):370-385. PMID: 24430863
- Tal R, et al. Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception. Fertil Steril. 2014;101(4):1063-1069. PMID: 24462055
- Steiner AZ, et al. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA. 2017;318(14):1367-1376. PMID: 29049651
- Zarek SM, et al. Antimüllerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction randomized trial. Am J Obstet Gynecol. 2016;214(4):494.e1-494.e7. PMID: 26874301